Alterity Therapeutics Ltd Adr stock is traded at $2.22, with a volume of 40,341. It is down -9.02% in the last 24 hours and down -34.12% over the past month. Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules. Its research and clinical development efforts are focused on Parkinson's disease and related disorders, where it is identifying and developing novel compounds that address the underlying pathology of these disorders by binding and redistributing excess labile iron, reducing alpha-synuclein aggregation, and rescuing neurons in the brain. Its pipeline programs are ATH434-201, ATH434-202, bioMUSE, ATH434, and Drug Discovery. The Group operated in one segment, research and development into Parkinsonian and other neurodegenerative disorders.
Previous Close:
$2.44
Open:
$2.35
24h Volume:
40,341
Relative Volume:
0.09
Market Cap:
$42.38M
Revenue:
-$41,600
Net Income/Loss:
-$9.46M
P/E Ratio:
-
EPS:
-$28.95
Net Cash Flow:
-$8.70M
1W Performance:
+2.78%
1M Performance:
-34.12%
6M Performance:
-50.88%
1Y Performance:
-36.57%
1-Day Range:
$0.00$0.00
1-Week Range:
$2.09$3.29
52-Week Range:
$2.01$5.89
Alterity Therapeutics Ltd Adr Stock (ATHE) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS